share_log

Solid Earnings Reflect Mingchen HealthLtd's (SZSE:002919) Strength As A Business

Solid Earnings Reflect Mingchen HealthLtd's (SZSE:002919) Strength As A Business

穩健的收益反映了明晨健康有限公司(深圳證券交易所:002919)的企業實力
Simply Wall St ·  05/04 21:09

Even though Mingchen Health Co.,Ltd.'s (SZSE:002919) recent earnings release was robust, the market didn't seem to notice. Our analysis suggests that investors might be missing some promising details.

儘管明晨健康有限公司, Ltd. 's(SZSE:002919)最近的業績表現強勁,市場似乎沒有注意到。我們的分析表明,投資者可能遺漏了一些令人鼓舞的細節。

earnings-and-revenue-history
SZSE:002919 Earnings and Revenue History May 5th 2024
SZSE: 002919 收益和收入歷史記錄 2024 年 5 月 5 日

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

Importantly, our data indicates that Mingchen HealthLtd's profit was reduced by CN¥30m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Mingchen HealthLtd to produce a higher profit next year, all else being equal.

重要的是,我們的數據表明,由於不尋常的項目,明晨健康有限公司的利潤比去年減少了3000萬元人民幣。看到不尋常的項目使公司利潤付出代價從來都不是一件好事,但從好的方面來看,情況可能遲早會好轉。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。而且,畢竟,這正是會計術語的含義。假設這些不尋常的支出不會再次出現,因此,我們預計明晨健康有限公司在其他條件相同的情況下,明年將實現更高的利潤。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Mingchen HealthLtd.

注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對Mingchen HealthLtd的資產負債表分析

Our Take On Mingchen HealthLtd's Profit Performance

我們對明晨健康有限公司盈利表現的看法

Because unusual items detracted from Mingchen HealthLtd's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Based on this observation, we consider it likely that Mingchen HealthLtd's statutory profit actually understates its earnings potential! And the EPS is up 28% over the last twelve months. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. You'd be interested to know, that we found 1 warning sign for Mingchen HealthLtd and you'll want to know about this.

由於不尋常的項目削弱了明晨健康有限公司去年的收益,你可能會爭辯說,我們可以預期本季度的業績會有所改善。基於這一觀察,我們認爲明晨健康有限公司的法定利潤可能實際上低估了其盈利潛力!在過去的十二個月中,每股收益增長了28%。本文的目標是評估我們在多大程度上可以依靠法定收益來反映公司的潛力,但還有很多需要考慮的地方。考慮到這一點,除非我們對風險有透徹的了解,否則我們不會考慮投資股票。你可能會有興趣知道,我們找到了 Mingchen HealthLtd 的 1 個警告標誌,你會想知道的。

This note has only looked at a single factor that sheds light on the nature of Mingchen HealthLtd's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

這份報告只考慮了揭示明晨健康有限公司利潤性質的單一因素。但是,還有很多其他方法可以讓你對公司的看法。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論